Top Page
Quantum Healthcare Ltd.
(SGX:V8Y)
Quantum Healthcare Ltd. (V8Y) vs. iShares MSCI Singapore ETF (EWS)
Quantum Healthcare Ltd. Business Overview & Revenue Model
Quantum Healthcare Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.94M | 12.69M | 13.08M | 9.37M | 0.00 |
| Gross Profit | 5.87M | 5.66M | 5.76M | 4.35M | -246.00K |
| EBITDA | 249.00K | -318.00K | -1.45M | -7.23M | -5.03M |
| Net Income | -1.83M | -2.23M | -3.62M | -9.07M | -5.28M |
Balance Sheet | |||||
| Total Assets | 11.55M | 12.53M | 13.03M | 14.45M | 916.00K |
| Cash, Cash Equivalents and Short-Term Investments | 199.00K | 386.00K | 744.00K | 5.07M | 344.00K |
| Total Debt | 6.86M | 7.64M | 6.51M | 7.55M | 997.00K |
| Total Liabilities | 14.93M | 15.50M | 16.06M | 15.35M | 3.55M |
| Stockholders Equity | -3.96M | -3.62M | -3.87M | -1.50M | -2.59M |
Cash Flow | |||||
| Free Cash Flow | 1.12M | 1.09M | -926.00K | -2.23M | -1.30M |
| Operating Cash Flow | 1.40M | 1.45M | -628.00K | -1.30M | -1.30M |
| Investing Cash Flow | 387.00K | -1.07M | -3.42M | -5.04M | 81.00K |
| Financing Cash Flow | -1.88M | -733.00K | -272.00K | 11.06M | 240.00K |
Quantum Healthcare Ltd. Peers Comparison
Quantum Healthcare Ltd. Corporate Events
Quantum Healthcare Ltd. announced a delay in its proposed placement of new ordinary shares due to incomplete administrative processes and the need for additional due diligence by the placees. The company has entered into a supplemental agreement to extend the completion date for the placement to November 30, 2025, indicating a strategic move to ensure compliance and successful execution of its financial plans.
Quantum Healthcare Ltd. has received approval from the SGX-ST for the listing and quotation of new ordinary shares related to a proposed placement, debt conversion, and directors’ fees capitalization. This development is contingent upon compliance with listing requirements and shareholder approval. The move is part of the company’s strategy to strengthen its capital structure and improve financial flexibility, potentially impacting its market positioning and stakeholder interests.
Quantum Healthcare Ltd. has announced an agreement to capitalize part of the outstanding director’s fees owed to Mr. Sho Kian Hin, a former independent director. The company will issue 58,157,091 new shares to Mr. Sho at a premium price to settle S$63,972.80 of the fees, leaving a balance of S$15,993.20. This move reflects the company’s strategic financial management and aims to maintain shareholder value by considering potential dilution and aligning with previous capitalisation terms.
Quantum Healthcare Ltd. has announced significant developments impacting its financial stability. The company previously relied on a going concern assumption based on a letter of support from Dr. Jimmy, a substantial shareholder, which assured that a loan from PW Dental would not be called for repayment. However, Dr. Jimmy has withdrawn this support due to the company’s inaction on fundraising opportunities, and PW Dental has demanded immediate repayment of the outstanding loan, raising concerns about the company’s financial health and its ability to meet obligations.
Quantum Healthcare Ltd. has announced an extension of its trading halt, which remains in effect as the company prepares and finalizes an important announcement. This decision indicates a significant pending development that could impact the company’s operations and market positioning, leaving stakeholders in anticipation of further details.